Heated vs. sprayed chemo: which works better for belly cancer?
NCT ID NCT07282834
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study compares two methods of giving chemotherapy directly into the abdomen for people whose cancer has spread there (peritoneal carcinomatosis). One method, HIPEC, uses heated chemotherapy circulated during surgery. The other, PIPAC, delivers chemotherapy as a pressurized spray during a minimally invasive procedure. The trial will enroll 200 adults to see which approach is safer, better tolerated, and more effective.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Mitomycin C (chemotherapy)
- What this could lead to
- If successful, this trial could identify which direct-to-abdomen chemotherapy method is safer and more tolerable for patients with cancer spread in the belly.
- What could go wrong
- This is a mid-stage trial with 200 participants, so results may not apply to all patients. Both methods involve chemotherapy side effects and surgical risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABDOMINAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Allegheny Health Network West Penn Hospital
RECRUITINGPittsburgh, Pennsylvania, 15224, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Lab-Grown tumor models predict the best therapy for each patient?
- Triple chemo cocktail aims to clear deadly bowel blockages in advanced stomach cancer
- Chemotherapy sprayed directly into the abdomen: a new attack on stubborn cancers
- New drug combo aims to tackle Chemotherapy-Resistant colorectal cancer in the abdomen
- Light-Activated therapy shows promise for tumor control without surgery
- Experimental shot takes aim at stomach cancer spread